German biotech BioNTech SE worked on cancer treatments, and was developing an influenza vaccine with Pfizer Inc., when its founder, Ugur Sahin, led the company’s pivot to the coronavirus in ...
An early deal with Merck was scotched for fear poor countries would be left out; now the university could make over $100 million with AstraZeneca if the technology succeeds.
Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and the impasse on fiscal stimulus. After...
As STAT celebrates its five-year anniversary, our reporters took a look back at areas we’ve covered closely and cast an eye to the future.
An inhaled neutralizing antibody cleared the novel coronavirus from infected hamsters at a far lower dose compared with other experimental monoclonal antibodies. The drug is now being ...
With anxiety already high over current drug supply lines, these policies would leave the country dependent on China for future medicines.
Bharat Biotech plans to launch the indigenously developed Covid-19 vaccine by June 2021. The pharma company was given nod to continue with phase III clinical trials on October 22. Covaxin ...
Scorpion Therapeutics, Inc. today announced the closing of a $108 million Series A financing.